Patents by Inventor David K. Gardner

David K. Gardner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210213053
    Abstract: A method of enhancing embryo implantation in a subject is disclosed which comprises administering to the uterine cavity of the subject a formulation comprising copper and/or zinc in an amount effective to stimulate endometrial production of leukaemia inhibitory factor (LIF) and/or vascular endothelial growth factor (VEGF). Alternatively, a device may be inserted into the uterine cavity of the subject, wherein the device comprises copper and/or zinc, for a period of time that is effective to stimulate endometrial production of LIF and/or VEGF. The method is suitable for use with women undergoing treatment by any of the assisted reproductive technologies, such as those involving the transfer of embryos such as in vitro fertilisation (IVF) and variants including IVF-ICSI (intracytoplasmic sperm injection) and in vitro maturation (IVM) treatments, as well as intrauterine-insemination (IUI) therapy.
    Type: Application
    Filed: May 29, 2019
    Publication date: July 15, 2021
    Applicants: The Flinders University of South Australia, The University of Melbourne
    Inventors: Kelton Paul Tremellen, David K. Gardner, Alexandra J. Harvey
  • Patent number: 8859280
    Abstract: A composition and method for in vitro fertilization is provided which uses culture media comprising elevated concentrations of lipoic acid. More specifically, the invention provides culture media for developmental cells having a lipoic acid concentration of 5 ?M to 40 ?M. Culture media that include lipoic acid at concentrations within the identified range are able to provide blastocysts with increased survival, increased cell numbers, increased inner cell masses and/or increased percentage of the total mass made up by the inner cell compared to blastocysts cultured in a control medium.
    Type: Grant
    Filed: August 23, 2013
    Date of Patent: October 14, 2014
    Assignee: Vitrolife Sweden AB
    Inventors: David K Gardner, Mark G Larman, Donald Linck
  • Publication number: 20130344595
    Abstract: A composition and method for in vitro fertilization is provided which uses culture media comprising elevated concentrations of lipoic acid. More specifically, the invention provides culture media for developmental cells having a lipoic acid concentration of 5 ?M to 40 ?M. Culture media that include lipoic acid at concentrations within the identified range are able to provide blastocysts with increased survival, increased cell numbers, increased inner cell masses and/or increased percentage of the total mass made up by the inner cell compared to blastocysts cultured in a control medium.
    Type: Application
    Filed: August 23, 2013
    Publication date: December 26, 2013
    Applicant: Vitrolife Sweden AB
    Inventors: David K. GARDNER, Mark G. LARMAN, Donald LINCK
  • Publication number: 20100173409
    Abstract: A composition and method for in vitro fertilization is provided which uses culture media comprising elevated concentrations of lipoic acid. More specifically, the invention provides culture media for developmental cells having a lipoic acid concentration of 5 ?M to 40 ?M. Culture media that include lipoic acid at concentrations within the identified range are able to provide blastocysts with increased survival, increased cell numbers, increased inner cell masses and/or increased percentage of the total mass made up by the inner cell compared to blastocysts cultured in a control medium.
    Type: Application
    Filed: April 10, 2008
    Publication date: July 8, 2010
    Applicant: VITROLIFE SWEDEN AB
    Inventors: David K. Gardner, Mark G. Larman, Donald Linck
  • Publication number: 20100099135
    Abstract: The present invention provides methods and assays for assessing the presence, viability and/or developmental stage of an embryo. The present invention also provides method and assays for assessing the quality of an Assisted Reproduction Technology protocol.
    Type: Application
    Filed: October 21, 2009
    Publication date: April 22, 2010
    Inventors: Mandy Katz-Jaffe, David K. Gardner
  • Publication number: 20090191534
    Abstract: Instead of immersing human reproductive cells in a single culture medium throughout the various procedures used in IVF, a process is provided by which the reproductive cells may be moved through a sequence of distinct culture media as the various IVF procedures are carried out. In one implementation, the culture media specifically formulated to provide a physical environment similar to that found within the female reproductive tract and conducive to growth and development of human reproductive cells during the various stages of the IVF process. In this regard, specifically formulated culture media can be applied to support the reproductive cells in one or more of the following procedures: oocyte retrieval and handling; oocyte maturation; ordinary fertilization; oocyte, zygote and embryo examination and biopsy; embryonic development to the eight-cell stage; embryonic development to the blastocyst stage; embryo transfer, and cryopreservation.
    Type: Application
    Filed: April 6, 2009
    Publication date: July 30, 2009
    Inventors: David K. GARDNER, Michelle T. LANE, Peter SVALANDER
  • Patent number: 6838235
    Abstract: Instead of immersing human reproductive cells in a single culture medium throughout the various procedures used in IVF, a process is provided by which the reproductive cells may be moved through a sequence of distinct culture media as the various IVF procedures are carried out. In one implementation, the culture media specifically formulated to provide a physical environment similar to that found within the female reproductive tract and conducive to growth and development of human reproductive cells during the various stages of the IVF process. In this regard, specifically formulated culture media can be applied to support the reproductive cells in one or more of the following procedures: oocyte retrieval and handling; oocyte maturation; ordinary fertilization; oocyte, zygote and embryo examination and biopsy; embryonic development to the eight-cell stage; embryonic development to the blastocyst stage; embryo transfer; and cryopreservation.
    Type: Grant
    Filed: December 18, 2002
    Date of Patent: January 4, 2005
    Assignee: Vitrolife Group
    Inventors: David K. Gardner, Michelle Lane
  • Publication number: 20040214320
    Abstract: The present invention provides a supplement and a culture media useful for culturing mammalian gametes and embryonic tissue. The culture media comprises at least one of recombinant human albumin, fermented hyaluronan, and citrate. Because the constituents are produced from non-conventional sources, the culture medium is free from contaminants such as viruses, prions and endotoxins. Additionally, because the medium is completely defined, the medium is not subject to variations which can impair the development of mammalian cells and prevent meaningful comparisons of empirical studies.
    Type: Application
    Filed: January 26, 2004
    Publication date: October 28, 2004
    Applicant: Vitrolife, Inc,
    Inventors: David K. Gardner, Michelle T. Lane
  • Patent number: 6762053
    Abstract: The present invention provides a supplement and a culture media useful for culturing mammalian gametes and embryonic tissue. The culture media comprises at least one of recombinant human albumin, fermented hyaluronan, and citrate. Because the constituents are produced from non-conventional sources, the culture medium is free from contaminants such as viruses, prions and endotoxins. Additionally, because the medium is completely defined, the medium is not subject to variations which can impair the development of mammalian cells and prevent meaningful comparisons of empirical studies.
    Type: Grant
    Filed: June 8, 2001
    Date of Patent: July 13, 2004
    Assignee: Vitrolife, Inc.
    Inventors: David K. Gardner, Michelle T. Lane
  • Publication number: 20030091972
    Abstract: Instead of immersing human reproductive cells in a single culture medium throughout the various procedures used in IVF, a process is provided by which the reproductive cells may be moved through a sequence of distinct culture media as the various IVF procedures are carried out. In one implementation, the culture media specifically formulated to provide a physical environment similar to that found within the female reproductive tract and conducive to growth and development of human reproductive cells during the various stages of the IVF process. In this regard, specifically formulated culture media can be applied to support the reproductive cells in one or more of the following procedures: oocyte retrieval and handling; oocyte maturation; ordinary fertilization; oocyte, zygote and embryo examination and biopsy; embryonic development to the eight-cell stage; embryonic development to the blastocyst stage; embryo transfer; and cryopreservation.
    Type: Application
    Filed: December 18, 2002
    Publication date: May 15, 2003
    Applicant: Vitrolife Group
    Inventors: David K. Gardner, Michelle Lane
  • Publication number: 20020042132
    Abstract: The present invention provides a supplement and a culture media useful for culturing mammalian gametes and embryonic tissue. The culture media comprises at least one of recombinant human albumin, fermented hyaluronan, and citrate. Because the constituents are produced from non-conventional sources, the culture medium is free from contaminants such as viruses, prions and endotoxins. Additionally, because the medium is completely defined, the medium is not subject to variations which can impair the development of mammalian cells and prevent meaningful comparisons of empirical studies.
    Type: Application
    Filed: June 8, 2001
    Publication date: April 11, 2002
    Inventors: David K. Gardner, Michelle T. Lane